Chemical Compound
Alfuzosin Hydrochloride
CAS Registry Number
81403-68-1
Primary Record
Alfuzosin Hydrochloride
- In stock
- 1,675 g
- Purity
- 98.1 %
- CAS
- 81403-68-1
Compound Identifiers & Properties
- CAS
- 81403-68-1
- PubChem CID
- 71764
- SMILES
- CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl
- Canonical SMILES
- COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl
Names & Synonyms
- Alfuzosin Hydrochloride
- Alfuzosin HCl
- Uroxatral
- Xatral
- Urion
- Alfoten
- 81403-68-1
- Alfetim
- Xatral SR
- Xatral Retard
- alfuzosin
- Xatral OD
- Xatral XL
- Benestan ret
- Alfutral sr
- Besavar xl
- Fuzatal xl
- Kelanu xl
- Vasran xl
- Uroxatral (TN)
- Zufal xl
- Urion s
- Alfuzosin-d7HCl
- Alfuzosin (hydrochloride)
- Atfuzosin Hydrochloride
- Alfuzosin hydrochloride [USAN]
- Alfuzosin-d3 Hydrochloride
- Alfuzosin hydrochloride;
- RefChem:54079
- AC1L2GRP
- AC1Q5PED
- ALFUZOSINHYDROCHLORIDE
- C19H28ClN5O4
- DTXSID3045514
- D0H1YQ
- Alfuzosin hydrochloride CRS
- UNII-75046A1XTN
- 75046A1XTN
- CHEMBL1723
- MFCD00879135
- Alfuzosin-[d6] hydrochloride
- DTXCID1025514
- C19H27N5O4.ClH
- SCHEMBL179910
- SL 77 499-10
- YTNKWDJILNVLGX-UHFFFAOYSA-N
- HY-B0192AR
- orb1310947
- Alfuzosin hydrochloride (Uroxatral)
- SCHEMBL29492949
- SCHEMBL30690015
- Alfuzosin for peak identification
- Alfuzosin hydrochloride (JAN/USAN)
- Alfuzosin hydrochloride [USAN:USP]
- CHEBI:32286
- CTK8F7637
- HY-B0192A
- ALFUZOSIN HYDROCHLORIDE 1G
- SL 77499-10
- Uroxatral, Alfuzosin hydrochloride
- Alfuzosin for system suitability A
- BCPP000417
- C19H27N5O4
- GLXC-23891
- HMS1569A05
- HMS5079P21
- CID71764
- KS-00000XK8
- SL-77499-10
- ALFUZOSIN HYDROCHLORIDE [MI]
- C19-H27-N5-O4.Cl-H
- Tox21_110701
- Tox21_500224
- Alfuzosin (hydrochloride) (Standard)
- ALFUZOSIN HYDROCHLORIDE [JAN]
- AR-1K4672
- EBC-11209
- RW2757
- s1409
- Alfuzosin for peak identification CRS
- ALFUZOSIN HYDROCHLORIDE 100MG
- SL-77499
- AKOS015966770
- Tox21_110701_1
- AC-1116
- Alfuzosin for system suitability A CRS
- ALFUZOSIN HYDROCHLORIDE [MART.]
- BCP9000271
- BLP-003258
- CCG-213373
- CS-2087
- CS-O-00515
- LP00224
- ALFUZOSIN HYDROCHLORIDE [USP-RS]
- ALFUZOSIN HYDROCHLORIDE [WHO-DD]
- Alfuzosin Hydrochloride Extended Release
- SL-77-499-10
- Alfuzosin hydrochloride, 99% - 1G 1g
- NCGC00016946-01
- NCGC00095152-09
- NCGC00260909-01
- SL-7749910
- AS-14240
- AT-12271
- BC677639
- K448
- LS-70107
- SL77.0499-10
- AB0008072
- AB2000094
- CAS-81403-68-1
- SL-77.0499-10
- A2591
- AK00451977
- Alfuzosin hydrochloride =98.0% (by HPLC)
- ALFUZOSIN HYDROCHLORIDE [ORANGE BOOK]
- FT-0630890
- SW196913-4
- ALFUZOSIN HYDROCHLORIDE [EP MONOGRAPH]
- ALFUZOSIN HYDROCHLORIDE [USP MONOGRAPH]
- D01692
- T71347
- Alfuzosin hydrochloride, >=98% (HPLC), solid
- 403A681
- A840121
- SR-01000759345
- Alfuzosin for peak identification CRS (Y0001883)
- N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide hydrochloride
- SR-01000759345-5
- 81403-68-1 (Alfuzosin HCl), 81403-80-7(Alfuzosin).
- Q27114856
- (+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride
- N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide hydrochloride
- n-{3-[(4-amino-6,7-dimethoxychinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamidhydrochlorid
- 1216383-97-9
- 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-
- Alfuzosin hydrochloride, European Pharmacopoeia (EP) Reference Standard
- Alfuzosin hydrochloride, United States Pharmacopeia (USP) Reference Standard
- N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide, monohydrochloride
- N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide;hydrochloride
- N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
- Alfuzosin for peak identification, European Pharmacopoeia (EP) Reference Standard
- Alfuzosin for system suitability A, European Pharmacopoeia (EP) Reference Standard
- Alfuzosin for system suitability, European Pharmacopoeia (EP) Reference Standard
- Alfuzosin hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
- (+-)-N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide Monohydrochloride
- (+/-)-N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)METHYLAMINO)PROPYL)TETRAHYDRO-2-FURAMIDE MONOHYDROCHLORIDE
- (RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl]tetrahydrofuran-2-carboxamide hydrochloride
- 1006717-24-3
- 2-FURANCARBOXAMIDE, (+/-)-N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)METHYLAMINO)PROPYL)TETRAHYDRO-, MONOHYDROCHLORIDE
- 2682-98-6
- 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride
- 81403-80-7
- Alfuzosin hydrochloride, (2RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]tetrahydrofuran-2-carboxamide hydrochloride, SL 77-499-10, SL 77499-10, Urion, Uroxatral, Xatral, Alfoten
- HCl
- N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide hydrochloride
- N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)-propyl)tetrahydrofuran-2-carboxamide hydrochloride
- N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride
- n-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
- N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
- N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide;hydrochloride
- N-{3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide--hydrogen chloride (1/1)